David Fournier, Allison Glasunow, and Kourtney Mueller Merrill joined Sheppard, Mullin, Richter & Hampton as partners in its intellectual property practice group and life sciences industry team, the firm announced Monday.
Fournier advises clients on pharmaceutical, biologic, medical device and consumer product patents, with a focus on exclusivity planning, strategic global portfolio development and regulatory compliance. He has actively been involved with abbreviated new drug application litigation, Orange Book listings, patent term extensions, Food and Drug Administration exclusivity, and post-grant proceedings, the firm said.
Glasunow advises life sciences companies on patent strategy, portfolio development, and legal issues related to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.